Infection and Immunity, August 2003, p. 4828, Vol. 71, No. 8
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.8.4828.2003
| RETRACTION |
Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
Volume 70, no. 3, p. 1279-1286, 2002. Subsequent to the publication of this article, we discovered that additional preparations of cloned Shiga toxin 2 (Stx2) B subunit lacked apoptogenic activity in Ramos Burkitt's lymphoma B cells. After exhaustive biological and biochemical characterization, we discovered that the Stx2 B subunit preparations used in our study contained previously undetected Stx2 holotoxin. Since this contaminating Stx2 holotoxin was likely responsible for the apoptogenic activity we attributed to the Stx2 B subunit in this article, we retract the conclusion that the Stx2 B subunit, absent any A subunit activity, initiated apoptosis in Ramos cells. This new finding does not alter our conclusions related to the lack of apoptogenic activity in the Stx1 B subunit preparation or the protective effect of Z-VAD-fmk on protein biosynthesis in the Stx2 B subunit-treated Ramos cells.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»